Strategic Growth Aqua focuses on expanding beyond its current dermatology portfolio through development, licensing, co-promotion, acquisitions, and partnerships, signaling readiness for new product opportunities and potential collaboration avenues.

Dermatology Focus Specialty dermatology focus with existing FDA-approved products provides a clear entry point for in-licensing or co-promotion of complementary skin conditions and treatment modalities in the US market.

Almirall Alliance As an Almirall subsidiary with a history of integration, Aqua can leverage parent company channels, distribution networks, and capital to pursue acquisitions or licenses that enhance market reach.

Growth Readiness Revenue range indicates a mid-market scale with potential for acceleration through expanded product lines, strategic partnerships, and targeted sales campaigns to dermatology specialists and clinics.

Market Positioning Existing product portfolio covers antibiotics, anti-inflammatories, antifungals, and corticosteroids, suggesting opportunities to cross-sell or co-market with partners focusing on adjacent dermatology indications.